Fractyl Health (NASDAQ:GUTS)公布的季度每股亏损为$(0.52)，低于分析师普遍预期的$(0.34)，差异为52.94%。与去年同期每股亏损$(11.18)相比，这一数据增长了95.35%。公司公布的季度销售额为$3.00千美元，低于分析师普遍预期的$10.00千美元，差异为70.00%。与去年同期$7.00千美元的销售额相比，这一数据下降了57.14%。

以上内容来自Benzinga Earnings专栏，原文如下：

Fractyl Health (NASDAQ:GUTS) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.34) by 52.94 percent. This is a 95.35 percent increase over losses of $(11.18) per share from the same period last year. The company reported quarterly sales of $3.00 thousand which missed the analyst consensus estimate of $10.00 thousand by 70.00 percent. This is a 57.14 percent decrease over sales of $7.00 thousand the same period last year.